Skip to content

Total Liabilities at other companies

Alkermes logo
AlkermesALKS
$2.51B+339%
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
$659.02M+21.3%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$48.4M-14.8%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$357.16M-2.7%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$134.91M+17.7%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$48.99M+24.6%

Other financials

Income statement

See full
Revenue$215.4M+16.6%
Gross profit$170.9M+11.9%
Operating income$37.3M-33.7%
Net income$32.5M-28.7%
EPS (diluted)$0.55-29.5%

Balance sheet

See full
Cash & equivalents$589.4M+20.5%
Total debt$164.6M-7.2%
Total equity$910.3M+26.3%
Total assets$1.3B+20.5%

Cash flow

See full
Operating cash flow$27.8M-18.3%
CapEx$107.0K-79.1%
Free cash flow$126.0M+67.9%

Valuation

See full
Market cap$1.98B-14.9%
Enterprise value$1.55B-24.9%
P/E13.6×-1.6×
P/S2.2×-0.9×

Profitability

See full
Gross margin76.5%-1.8pp
Operating margin21.1%-5.1pp
Net margin16.2%-4.3pp
FCF margin40.1%+9.5pp

Returns & leverage

See full
Return on equity17.9%-6.9pp
Debt / equity0.2×-0.1×
Current ratio3.6×-0.1×

Where this comes from

Reported directly by Harmony Biosciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Liabilities.

The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harmony Biosciences Holdings, Inc.'s total liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harmony Biosciences Holdings, Inc.'s total liabilities?
Harmony Biosciences Holdings, Inc. (HRMY) reported total liabilities of $361.48M in Q1 2026.
How has Harmony Biosciences Holdings, Inc.'s total liabilities changed year-over-year?
Harmony Biosciences Holdings, Inc.'s total liabilities increased by 7.9% year-over-year, from $335.01M to $361.48M.
What is the long-term trend for Harmony Biosciences Holdings, Inc.'s total liabilities?
Over 5 years (2020 to 2025), Harmony Biosciences Holdings, Inc.'s total liabilities has grown at a 4.0% compound annual growth rate (CAGR), from $329.89M to $401.41M.
What does total liabilities mean?
The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.